Dexamethasone Clinically Proven a Life-saving Drug for Covid-19
A recent clinical trial has demonstrated the anti-inflammatory, anti-IL-6 effect of dexamethasone to be powerful in reducing mortality for Covid-19 patients.
A Major Breakthrough Sees Institutional Support
The results of the clinical trial are both clear and potent.
The clinical trial, led by a team at Oxford University, covered 2,104 hospital patients given dexamethasone with results compared to a control of more than 4,321 patients.
For patients on ventilators, the risk of death was cut from 40% to 28%.
For patients needing oxygen, the risk of death was cut from 25% to 20%.
Overall, the study authors concluded that, "1 death would be prevented by treatment of around 8 ventilated patients or around 25 patients requiring oxygen alone."
Fortunately, it is globally widely available and for cheap, with a price tag as low as just $11 for a full course of medication in tablet form.
As used in the trial, 6mg were taken for a recommended duration of not longer then 10 days.
The drug is to be administered intravenously for severe cases.
Dexamethasone is specifically useful for treating high-risk patients, as it works to simmer down the cytokine storm that instigates death in many severe cases of Covid-19.
The drug is already used to reduce inflammation in a range of other conditions, including arthritis, asthma and some skin conditions, hence its wide, current availability.